|
|
Volumn 22, Issue 3, 2013, Pages 362-364
|
|
Everyday clinical practice and its relationship to 2010 and 2011 gold guideline recommendations for the management of COPD
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
CORTICOSTEROID;
LONG ACTING DRUG;
MUSCARINIC RECEPTOR BLOCKING AGENT;
ADULT;
AGED;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL PRACTICE;
CLINICAL PROTOCOL;
COHORT ANALYSIS;
COMPARATIVE EFFECTIVENESS;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
FORCED EXPIRATORY VOLUME;
FORCED VITAL CAPACITY;
HEALTH CARE PLANNING;
HEALTH CARE QUALITY;
HIGH RISK PATIENT;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL HISTORY;
MONOTHERAPY;
PATIENT ATTITUDE;
PATIENT CODING;
SPIROMETRY;
TREATMENT OUTCOME;
TREND STUDY;
ADMINISTRATION, INHALATION;
ADRENAL CORTEX HORMONES;
ADRENERGIC BETA-2 RECEPTOR AGONISTS;
AGED;
AGED, 80 AND OVER;
COHORT STUDIES;
FEMALE;
GUIDELINE ADHERENCE;
HUMANS;
MALE;
MIDDLE AGED;
MUSCARINIC ANTAGONISTS;
PHYSICIAN'S PRACTICE PATTERNS;
PRACTICE GUIDELINES AS TOPIC;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
|
|
EID: 84883455643
PISSN: 14714418
EISSN: 14751534
Source Type: Journal
DOI: 10.4104/pcrj.2013.00073 Document Type: Letter |
|
Times cited : (16)
|
|
References (7)
|
